Literature DB >> 21419566

Defining a patient-reported outcome measure for urethral stricture surgery.

Matthew J Jackson1, John Sciberras, Altaf Mangera, Andrew Brett, Nick Watkin, James M O N'dow, Christopher R Chapple, Daniela E Andrich, Robert S Pickard, Anthony R Mundy.   

Abstract

BACKGROUND: A systematic literature review did not identify a formally validated patient-reported outcome measure (PROM) for urethral stricture surgery.
OBJECTIVE: Devise a PROM for urethral stricture surgery and evaluate its psychometric properties in a pilot study to determine suitability for wider implementation. DESIGN, SETTING, AND PARTICIPANTS: Constructs were identified from existing condition-specific and health-related quality of life (HRQoL) instruments. Men scheduled for urethroplasty were prospectively enrolled at five centres. INTERVENTION: Participants self-completed the draft PROM before and 6 mo after surgery. MEASUREMENTS: Question sets underwent psychometric assessment targeting criterion and content validity, test-retest reliability, internal consistency, acceptability, and responsiveness. RESULTS AND LIMITATIONS: A total of 85 men completed the preoperative PROM, with 49 also completing the postoperative PROM at a median of 146 d; and 31 the preoperative PROM twice at a median interval of 22 d for test-retest analysis. Expert opinion and patient feedback supported content validity. Excellent correlation between voiding symptom scores and maximum flow rate (r = -0.75), supported by parallel improvements in EQ-5D visual analogue and time trade-off scores, established criterion validity. Test-retest intraclass correlation coefficients ranged from 0.83 to 0.91 for the total voiding score and 0.93 for the construct overall; Cronbach's α was 0.80, ranging from 0.76 to 0.80 with any one item deleted. Item-total correlations ranged from 0.44 to 0.63. These values surpassed our predefined thresholds for item inclusion. Significant improvements in condition-specific and HRQoL components following urethroplasty demonstrated responsiveness to change (p < 0.0001). Wider implementation and review of the PROM will be required to establish generalisability across different disease states and for more complex interventions.
CONCLUSIONS: This pilot study has defined a succinct, practical, and psychometrically robust PROM designed specifically to quantify changes in voiding symptoms and HRQoL following urethral stricture surgery.
Copyright © 2011 European Association of Urology. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21419566     DOI: 10.1016/j.eururo.2011.03.003

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  50 in total

1.  The outcomes of Kulkarni's one-stage oral mucosa graft urethroplasty in patients with panurethral stricture: a single centre experience.

Authors:  Ali Ersin Zumrutbas; Yusuf Ozlulerden; Sinan Celen; Kursat Kucuker; Zafer Aybek
Journal:  World J Urol       Date:  2019-04-08       Impact factor: 4.226

2.  Long-term follow-up of urethral reconstruction for blunt urethral injury at a young age: urinary and sexual quality of life outcomes.

Authors:  N Baradaran; J W McAninch; H L Copp; K Quanstrom; B N Breyer; L A Hampson
Journal:  J Pediatr Urol       Date:  2019-03-06       Impact factor: 1.830

3.  Psychometric validation of a German language version of a PROM for urethral stricture surgery and preliminary testing of supplementary ED and UI constructs.

Authors:  Luis A Kluth; Roland Dahlem; Andreas Becker; Marianne Schmid; Armin Soave; Clemens Rosenbaum; Tim A Ludwig; Natalie Christ; Michael Rink; Philip Reiss; Oliver Engel; Silke Riechardt; Felix K-H Chun; Margit Fisch; Sascha A Ahyai
Journal:  World J Urol       Date:  2015-06-07       Impact factor: 4.226

4.  Urinary tract obstruction: New PROM questionnaire for urethral stricture surgery.

Authors:  Katrina Ray
Journal:  Nat Rev Urol       Date:  2011-05       Impact factor: 14.432

5.  The International Prostate Symptom Score (IPSS) Is an Inadequate Tool to Screen for Urethral Stricture Recurrence After Anterior Urethroplasty.

Authors:  Christopher A Tam; Sean P Elliott; Bryan B Voelzke; Jeremy B Myers; Alex J Vanni; Benjamin N Breyer; Thomas G Smith; Christopher D McClung; Bradley A Erickson
Journal:  Urology       Date:  2016-04-21       Impact factor: 2.649

6.  Urethral stricture disease: Measuring success in treatment.

Authors:  Timothy O Davies
Journal:  Can Urol Assoc J       Date:  2012-08       Impact factor: 1.862

7.  Clinical significance of cystoscopic urethral stricture recurrence after anterior urethroplasty: a multi-institution analysis from Trauma and Urologic Reconstructive Network of Surgeons (TURNS).

Authors:  Nima Baradaran; Kirkpatrick B Fergus; Rachel A Moses; Darshan P Patel; Thomas W Gaither; Bryan B Voelzke; Thomas G Smith; Bradley A Erickson; Sean P Elliott; Nejd F Alsikafi; Alex J Vanni; Jill Buckley; Lee C Zhao; Jeremy B Myers; Benjamin N Breyer
Journal:  World J Urol       Date:  2019-02-02       Impact factor: 4.226

8.  Open urethroplasty versus endoscopic urethrotomy for recurrent urethral stricture in men: the OPEN RCT.

Authors:  Robert Pickard; Beatriz Goulao; Sonya Carnell; Jing Shen; Graeme MacLennan; John Norrie; Matt Breckons; Luke Vale; Paul Whybrow; Tim Rapley; Rebecca Forbes; Stephanie Currer; Mark Forrest; Jennifer Wilkinson; Elaine McColl; Daniela Andrich; Stewart Barclay; Jonathan Cook; Anthony Mundy; James N'Dow; Stephen Payne; Nick Watkin
Journal:  Health Technol Assess       Date:  2020-11       Impact factor: 4.014

9.  The UREThRAL stricture score: A novel method for describing anterior urethral strictures.

Authors:  Lucas R Wiegand; Steven B Brandes
Journal:  Can Urol Assoc J       Date:  2012-08       Impact factor: 1.862

10.  A drug-coated balloon treatment for urethral stricture disease: Two-year results from the ROBUST I study.

Authors:  Rachel A Mann; Ramón Virasoro; Jessica M DeLong; Rafael E Estrella; Merycarla Pichardo; Ramón Rodríguez Lay; Gustavo Espino; Joshua D Roth; Sean P Elliott
Journal:  Can Urol Assoc J       Date:  2021-02       Impact factor: 1.862

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.